NASDAQ : NVDA
NVIDIA Corporation — Key statistics
Technology · Semiconductors · United States
Last price 204.64 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.94T
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.06T |
| Enterprise Value | 5.03T |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Sep 10, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 24.15B |
| Shares Outstanding | 24.15B |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | -0.43% |
| Owned by Insiders (%) | 3.90% |
| Owned by Institutions (%) | 70.83% |
| Float | 23.18B |
Ratios
| Measure | Value |
|---|
| PE Ratio | 26.48 |
| Forward PE | 17.30 |
| PS Ratio | 16.58 |
| Forward PS | 9.33 |
| PB Ratio | 21.58 |
| P/TBV Ratio | 24.52 |
| P/FCF Ratio | 39.55 |
| P/OCF Ratio | 37.39 |
| PEG Ratio | 0.34 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.92 |
| EV / Sales | 16.50 |
| EV / EBITDA | 24.84 |
| EV / EBIT | 25.30 |
| EV / FCF | 39.36 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.59 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.31 |
| Interest Coverage | 425.82 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 117.21% |
| Return on Assets (ROA) | 53.57% |
| Return on Invested Capital (ROIC) | 92.03% |
| Return on Capital Employed (ROCE) | 71.26% |
| Weighted Average Cost of Capital (WACC) | 16.32% |
| Revenue Per Employee | $7.21M |
| Profits Per Employee | $4.59M |
| Employee Count | 42,000 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 3.30 |
Taxes
| Measure | Value |
|---|
| Income Tax | 36.86B |
| Effective Tax Rate | 16.05% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.22 |
| 52-Week Price Change | +3.37% |
| 50-Day Moving Average | 221.64 |
| 200-Day Moving Average | 204.50 |
| Relative Strength Index (RSI) | 40.70 |
| Average Volume (20 Days) | 95,812,264 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 301.62M |
| Short Previous Month | 311.39M |
| Short % of Shares Out | 1.25% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 2.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 302.97B |
| Gross Profit | 226.24B |
| Operating Income | 197.58B |
| Pretax Income | 229.74B |
| Net Income | 192.88B |
| EBITDA | 201.27B |
| EBIT | 197.58B |
| Earnings Per Share (EPS) | $7.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 62.47B |
| Total Debt | 38.86B |
| Net Cash | 23.61B |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 228.98B |
| Book Value Per Share | 9.48 |
| Working Capital | 154.39B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 134.36B |
| Capital Expenditures | -7.35B |
| Depreciation & Amortization | 3.69B |
| Net Borrowing | 24.90B |
| Free Cash Flow | 127.01B |
| FCF Per Share | $5.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | 74.67% |
| Operating Margin | 65.21% |
| Pretax Margin | 75.83% |
| Profit Margin | 63.66% |
| EBITDA Margin | 66.43% |
| EBIT Margin | 65.21% |
| FCF Margin | 41.92% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.00 |
| Dividend Yield | 0.48% |
| Dividend Growth (YoY) | 1,200.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 6.58% |
| FCF Payout Ratio | 9.89% |
| Buyback Yield | 1.04% |
| Shareholder Yield | 1.52% |
| Earnings Yield | 3.78% |
| FCF Yield | 2.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $328.95 |
| Price Target Difference | 57.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 62 |
| Revenue Growth Forecast (3Y) | 61.12% |
| EPS Growth Forecast (3Y) | 64.78% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 10, 2024 |
| Split Type | Forward |
| Split Ratio | 10:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 34.85 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |